STAAR Surgical Company (STAA) Financial Statements (2024 and earlier)

Company Profile

Business Address 1911 WALKER AVE
MONROVIA, CA 91016
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3851 - Ophthalmic Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q1
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments220,726188,113192,007203,847211,639211,333
Cash and cash equivalents183,038127,43294,69589,96886,480129,242
Short-term investments37,68860,68197,312113,879125,15982,091
Receivables97,160114,55698,32268,17165,11356,984
Inventory, net of allowances, customer advances and progress billings35,13031,06125,48227,80824,16119,930
Inventory35,13031,06125,48227,80824,16119,930
Prepaid expense6,2165,8304,9685,2453,9863,716
Other current assets762932668536811424
Other undisclosed current assets5,2756,5766,5567,2646,0134,523
Total current assets:365,269347,068328,003312,871311,723296,910
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization183220257303342380
Operating lease, right-of-use asset34,38734,99231,53031,18230,27029,503
Property, plant and equipment66,83562,88655,92453,45350,92148,048
Long-term investments and receivables11,70313,62717,52513,44513,90213,360
Long-term investments11,70313,62717,52513,44513,90213,360
Intangible assets, net (including goodwill)1,7861,7861,7861,9511,9591,957
Goodwill1,7861,7861,7861,7861,7861,786
Intangible assets, net (excluding goodwill)    165173171
Deferred income tax assets5,1908,5604,6724,7444,8243,710
Other noncurrent assets3,3392,382954956957808
Total noncurrent assets:123,423124,453112,648106,034103,17597,766
TOTAL ASSETS:488,692471,521440,651418,905414,898394,676
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,5578,78611,4419,10211,5767,567
Accounts payable13,5578,78611,4419,10211,5767,567
Debt165164162171169167
Other liabilities40,93836,26531,92528,94930,74129,072
Other undisclosed current liabilities10,37611,56010,6668,8419,2308,514
Total current liabilities:65,03656,77554,19447,06351,71645,320
Noncurrent Liabilities
Long-term debt and lease obligation 428412516721026,284
Finance lease, liability 4284125167210252
Liabilities, other than long-term debt37,66036,06732,63532,75130,7802,940
Asset retirement obligations10398101218220158
Deferred income tax liabilities1,0771,2951,2951,3691,4891,554
Liability, pension and other postretirement and postemployment benefits5,0553,0313,0503,1341,9351,228
Operating lease, liability31,42531,64328,18928,03027,13626,032
Total noncurrent liabilities:37,70236,15132,76032,91830,99029,224
Total liabilities:102,73892,92686,95479,98182,70674,544
Equity
Equity, attributable to parent385,954378,595353,697338,924332,192320,132
Common stock488488485483482482
Additional paid in capital436,947436,117419,594409,303404,189398,448
Accumulated other comprehensive income (loss)(4,113)(2,886)(2,521)(937)156(310)
Accumulated deficit(47,368)(55,124)(63,861)(69,925)(72,635)(78,488)
Total equity:385,954378,595353,697338,924332,192320,132
TOTAL LIABILITIES AND EQUITY:488,692471,521440,651418,905414,898394,676

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q1
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues76,27380,30892,30673,52864,04476,046
Cost of revenue
(Cost of Goods and Services Sold)
(15,548)(16,670)(21,580)(15,966)(14,259)(15,584)
Gross profit:60,72563,63870,72657,56249,78560,462
Operating expenses(50,320)(57,343)(62,129)(54,762)(48,821)(46,757)
Operating income (loss):10,4056,2958,5972,80096413,705
Nonoperating income (expense)3,334451(105)1,9195,015(1,128)
Investment income, nonoperating 74  27777
Gain (loss), foreign currency transaction, before tax1,331(1,384)(1,890)343,197(2,129)
Other nonoperating income3047110632727
Interest and debt expense(2)(3)(3)(4)(4)(5)
Income (loss) from continuing operations before equity method investments, income taxes:13,7376,7438,4894,7155,97512,572
Other undisclosed income from continuing operations before income taxes233445
Income (loss) from continuing operations before income taxes:13,7396,7468,4924,7195,97912,577
Income tax expense(5,983)(1,929)(2,428)(2,009)(126)(2,315)
Income (loss) from continuing operations:7,7564,8176,0642,7105,85310,262
Income before gain (loss) on sale of properties:10,262
Net income (loss) available to common stockholders, diluted:7,7564,8176,0642,7105,85310,262

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q1
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss):7,7564,8176,0642,7105,85310,262
Other comprehensive income (loss)(1,227)(365)(1,584)(1,093)466(559)
Comprehensive income (loss), net of tax, attributable to parent:6,5294,4524,4801,6176,3199,703

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: